# Healthpeak Properties, Inc.: financial statements, quarterly

DOC · NYSE · CIK 765880 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/doc.md) · [Financials](/companies/doc/financials.md) · [Filings](/companies/doc/filings.md) · [Insiders](/companies/doc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/doc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [134](/filings/0001628280-24-043814.md) | [136 d](/filings/0001628280-26-005044.md) | [139](/filings/0001628280-25-019948.md) | [141](/filings/0001628280-25-036063.md) | [143](/filings/0001628280-25-046273.md) | [146 d](/filings/0001628280-26-005044.md) | [149](/filings/0001628280-26-031287.md) | [149](/filings/0001628280-26-053373.md) | [150](/filings/0001628280-25-046273.md) | [156 d](/filings/0001628280-26-005044.md) | [200](/filings/0001628280-26-031287.md) | [216](/filings/0001628280-26-053373.md) |
| Cost of revenue | $m | [233](/filings/0001628280-24-043814.md) | [224 d](/filings/0001628280-25-003748.md) | [244](/filings/0001628280-25-019948.md) | [274](/filings/0001628280-25-036063.md) | [280](/filings/0001628280-25-046273.md) | [277 d](/filings/0001628280-25-003748.md) | [273](/filings/0001628280-25-019948.md) | [276](/filings/0001628280-25-036063.md) | [292](/filings/0001628280-25-046273.md) | not reported | not reported | not reported |
| Interest expense | $m | [50.5](/filings/0001628280-24-043814.md) | [52.8 d](/filings/0001628280-26-005044.md) | [60.9](/filings/0001628280-25-019948.md) | [74.9](/filings/0001628280-25-036063.md) | [74.1](/filings/0001628280-25-046273.md) | [70.5 d](/filings/0001628280-26-005044.md) | [72.7](/filings/0001628280-26-031287.md) | [75.1](/filings/0001628280-26-053373.md) | [76.8](/filings/0001628280-25-046273.md) | [80.6 d](/filings/0001628280-26-005044.md) | [87.3](/filings/0001628280-26-031287.md) | [92.3](/filings/0001628280-26-053373.md) |
| Income tax | $m | [0.8](/filings/0001628280-24-043814.md) | [(11.8) d](/filings/0001628280-26-005044.md) | [13.7](/filings/0001628280-25-019948.md) | [2.7](/filings/0001628280-25-036063.md) | [1.9](/filings/0001628280-25-046273.md) | [(14.0) d](/filings/0001628280-26-005044.md) | [2.1](/filings/0001628280-26-031287.md) | [2.4](/filings/0001628280-26-053373.md) | [(1.2)](/filings/0001628280-25-046273.md) | [6.0 d](/filings/0001628280-26-005044.md) | [0.3](/filings/0001628280-26-031287.md) | [(1.4)](/filings/0001628280-26-053373.md) |
| Net income | $m | [64.2](/filings/0001628280-24-043814.md) | [70.9 d](/filings/0001628280-26-005044.md) | [6.7](/filings/0001628280-25-019948.md) | [146](/filings/0001628280-25-036063.md) | [85.9](/filings/0001628280-25-046273.md) | [4.5 d](/filings/0001628280-26-005044.md) | [42.8](/filings/0001628280-26-031287.md) | [31.7](/filings/0001628280-26-053373.md) | [(117)](/filings/0001628280-25-046273.md) | [114 d](/filings/0001628280-26-005044.md) | [194](/filings/0001628280-26-031287.md) | [52.8](/filings/0001628280-26-053373.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001628280-24-043814.md) | not reported | [0.01](/filings/0001628280-25-019948.md) | [0.21](/filings/0001628280-25-036063.md) | [0.12](/filings/0001628280-25-046273.md) | not reported | [0.06](/filings/0001628280-26-031287.md) | [0.05](/filings/0001628280-26-053373.md) | [(0.17)](/filings/0001628280-25-046273.md) | not reported | [0.28](/filings/0001628280-26-031287.md) | [0.08](/filings/0001628280-26-053373.md) |
| Basic EPS | $ per share | [0.12](/filings/0001628280-24-043814.md) | not reported | [0.01](/filings/0001628280-25-019948.md) | [0.21](/filings/0001628280-25-036063.md) | [0.12](/filings/0001628280-25-046273.md) | not reported | [0.06](/filings/0001628280-26-031287.md) | [0.05](/filings/0001628280-26-053373.md) | [(0.17)](/filings/0001628280-25-046273.md) | not reported | [0.28](/filings/0001628280-26-031287.md) | [0.08](/filings/0001628280-26-053373.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001628280-24-043814.md) | [0.1](/filings/0001628280-25-046273.md) | [0.1](/filings/0001628280-25-019948.md) | [0.1](/filings/0001628280-25-036063.md) | [0.2](/filings/0001628280-25-046273.md) | [0.1](/filings/0001628280-26-053373.md) | [0.1](/filings/0001628280-26-031287.md) | [0.1](/filings/0001628280-26-053373.md) | [0.1](/filings/0001628280-25-046273.md) | [0.5](/filings/0001628280-26-053373.md) | [1.2](/filings/0001628280-26-031287.md) | [1.6](/filings/0001628280-26-053373.md) |
| Total assets | $bn | [15.6](/filings/0001628280-23-035504.md) | [15.7](/filings/0001628280-25-003748.md) | [20.5](/filings/0001628280-24-018706.md) | [20.2](/filings/0001628280-24-033154.md) | [20.0](/filings/0001628280-24-043814.md) | [19.9](/filings/0001628280-26-005044.md) | [19.8](/filings/0001628280-25-019948.md) | [19.8](/filings/0001628280-25-036063.md) | [19.6](/filings/0001628280-25-046273.md) | [20.3](/filings/0001628280-26-053373.md) | [21.6](/filings/0001628280-26-031287.md) | [21.7](/filings/0001628280-26-053373.md) |
| Total liabilities | $bn | [8.6](/filings/0001628280-23-035504.md) | [8.8](/filings/0001628280-25-003748.md) | [10.9](/filings/0001628280-24-018706.md) | [10.8](/filings/0001628280-24-033154.md) | [10.7](/filings/0001628280-24-043814.md) | [10.9](/filings/0001628280-26-005044.md) | [11.0](/filings/0001628280-25-019948.md) | [11.2](/filings/0001628280-25-036063.md) | [11.3](/filings/0001628280-25-046273.md) | [12.0](/filings/0001628280-26-053373.md) | [12.6](/filings/0001628280-26-031287.md) | [12.2](/filings/0001628280-26-053373.md) |
| Long-term debt | $bn | [6.7](/filings/0001628280-23-035504.md) | [6.9](/filings/0001628280-24-004094.md) | [8.8](/filings/0001628280-24-018706.md) | [8.6](/filings/0001628280-24-033154.md) | [8.6](/filings/0001628280-24-043814.md) | [8.7](/filings/0001628280-25-003748.md) | [8.9](/filings/0001628280-25-019948.md) | [9.0](/filings/0001628280-25-036063.md) | [9.1](/filings/0001628280-25-046273.md) | [9.8](/filings/0001628280-26-005044.md) | [10.4](/filings/0001628280-26-031287.md) | [10.0](/filings/0001628280-26-053373.md) |
| Shareholders' equity | $bn | [6.5](/filings/0001628280-23-035504.md) | [6.4](/filings/0001628280-25-003748.md) | [8.9](/filings/0001628280-24-018706.md) | [8.8](/filings/0001628280-24-033154.md) | [8.6](/filings/0001628280-24-043814.md) | [8.4](/filings/0001628280-26-005044.md) | [8.2](/filings/0001628280-25-019948.md) | [7.9](/filings/0001628280-25-036063.md) | [7.6](/filings/0001628280-25-046273.md) | [7.5](/filings/0001628280-26-053373.md) | [7.8](/filings/0001628280-26-031287.md) | [7.8](/filings/0001628280-26-053373.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [253 d](/filings/0001628280-24-043814.md) | [231 d](/filings/0001628280-26-005044.md) | [153](/filings/0001628280-25-019948.md) | [316 d](/filings/0001628280-25-036063.md) | [318 d](/filings/0001628280-25-046273.md) | [284 d](/filings/0001628280-26-005044.md) | [279](/filings/0001628280-26-031287.md) | [363 d](/filings/0001628280-26-053373.md) | [315 d](/filings/0001628280-25-046273.md) | [294 d](/filings/0001628280-26-005044.md) | [261](/filings/0001628280-26-031287.md) | [361 d](/filings/0001628280-26-053373.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [164 d](/filings/0001628280-24-043814.md) | [164 d](/filings/0001628280-26-005044.md) | [164](/filings/0001628280-25-019948.md) | [211 d](/filings/0001628280-25-036063.md) | [210 d](/filings/0001628280-25-046273.md) | [210 d](/filings/0001628280-26-005044.md) | [213](/filings/0001628280-26-031287.md) | [212 d](/filings/0001628280-26-053373.md) | [212 d](/filings/0001628280-25-046273.md) | [212 d](/filings/0001628280-26-005044.md) | [212](/filings/0001628280-26-031287.md) | [210 d](/filings/0001628280-26-053373.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-043814.md) | [0.0 d](/filings/0001628280-26-005044.md) | [102](/filings/0001628280-25-019948.md) | [68.2 d](/filings/0001628280-25-036063.md) | [20.1 d](/filings/0001628280-25-046273.md) | [0.3 d](/filings/0001628280-26-005044.md) | [25.0](/filings/0001628280-26-031287.md) | [72.1 d](/filings/0001628280-26-053373.md) | [0.0 d](/filings/0001628280-25-046273.md) | [0.1 d](/filings/0001628280-26-005044.md) | [1.4](/filings/0001628280-26-031287.md) | [100 d](/filings/0001628280-26-053373.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [546](/filings/0001628280-23-035504.md) | [547](/filings/0001628280-24-018706.md) | [547](/filings/0001628280-24-033154.md) | [547](/filings/0001628280-24-043814.md) | [601](/filings/0001628280-25-019948.md) | [703](/filings/0001628280-25-036063.md) | [700](/filings/0001628280-25-046273.md) | [699](/filings/0001628280-26-031287.md) | [695](/filings/0001628280-26-053373.md) | [695](/filings/0001628280-25-046273.md) | [695](/filings/0001628280-26-031287.md) | [690](/filings/0001628280-26-053373.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 689,527,260 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053373.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.